Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZIVO | AMGN | VRTX | REGN | BMY |
| Company | Zivo Bioscience | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 7.9200 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 7.9200 | 278.52 | 403.92 | 921.51 | 44.42 |
| Low | 7.9000 | 275.10 | 398.75 | 891.30 | 43.33 |
| Last | 7.9000 | 277.20 | 400.57 | 916.52 | 43.86 |
| Change | +1.3500 | -0.17 | -1.57 | +13.04 | -0.35 |
| % Change | +20.61% | -0.06% | -0.39% | +1.44% | -0.79% |
| Volume | 400 | 296,649 | 119,581 | 147,319 | 2,950,164 |
| 20-Day Average Volume | 1,390 | 2,126,071 | 954,734 | 460,519 | 13,557,732 |
| Previous Close | 6.5500 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.9088 | 270.11 | 398.79 | 907.83 | 47.83 |
| 20-Day Raw Stochastic | 59.45% | 82.62% | 56.40% | 48.02% | 0.43% |
| 20-Day Relative Strength | 50.87% | 51.92% | 47.47% | 45.66% | 27.37% |
| Weighted Alpha | -69.09 | +14.07 | +14.59 | +18.51 | -37.32 |
| Today's Opinion | 24% Buy | 24% Sell | 8% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 8% Buy | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 72% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.49% since 04/17/24 | +2.65% since 04/25/24 | +1.00% since 04/25/24 | +2.29% since 04/25/24 | -2.32% since 04/25/24 |
| Low | 6.5500 on 04/29/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.63 on 05/02/24 |
| High | 8.1000 on 04/29/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 921.51 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | +1.94% since 03/28/24 | +0.11% since 04/02/24 | -1.89% since 04/02/24 | -4.57% since 04/02/24 | -17.21% since 04/02/24 |
| Low | 6.5500 on 04/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.63 on 05/02/24 |
| High | 8.1000 on 04/29/24 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | -0.13% since 01/30/24 | -14.44% since 02/02/24 | -5.42% since 02/02/24 | -3.61% since 02/02/24 | -10.36% since 02/02/24 |
| Low | 6.2500 on 02/06/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.63 on 05/02/24 |
| High | 10.2100 on 02/21/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +203.85% since 10/30/23 | +3.72% since 11/02/23 | +6.67% since 11/02/23 | +11.27% since 11/02/23 | -14.60% since 11/02/23 |
| Low | 0.4800 on 11/29/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.63 on 05/02/24 |
| High | 13.0000 on 01/24/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 22,144 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 2,803 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 30,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -7,780,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 10,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,910,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.20 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.96 on 03/15/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |